Clinical Trial Update: Study to Evaluate the Safety, Tolerability and Pharmacokinetic of Single and 14 Day Repeat Topical Application of GSK1940029 [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating safety, tolerability, and pharmacokinetics of single and 14-day repeat topical application of the investigational drug GSK194002…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• GSK1940029

Snippet

Sponsor: GlaxoSmithKline | Conditions: Acne Vulgaris | Phase 1 | Status: COMPLETED